Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics?

A study reported in this issue of The Oncologist examined the utility of next-generation sequencing (NGS) in detecting ALK rearrangements. NGS may one day become the standard initial test for molecular genotyping of patients with advanced cancers, and this new generation of ALK diagnostics is a welc...

Descripción completa

Detalles Bibliográficos
Autores principales: Dagogo-Jack, Ibiayi, Shaw, Alice T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2016
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912373/
https://www.ncbi.nlm.nih.gov/pubmed/27245570
http://dx.doi.org/10.1634/theoncologist.2016-0179
Descripción
Sumario:A study reported in this issue of The Oncologist examined the utility of next-generation sequencing (NGS) in detecting ALK rearrangements. NGS may one day become the standard initial test for molecular genotyping of patients with advanced cancers, and this new generation of ALK diagnostics is a welcome addition to the current screening repertoire.

Ejemplares similares